CALIFORNIA INST BIOLOG RES has a total of 13 patent applications. Its first patent ever was published in 1989. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are KIM CHEOL MIN, INFECTIO DIAGNOSTIC INC and NUCLEICS PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Mcclelland Michael | 7 |
#2 | Lernhardt Waldemar | 5 |
#3 | Peinado Miguel Angel | 4 |
#4 | Welsh John | 4 |
#5 | Perucho Manuel | 4 |
#6 | Ionov Yurij | 4 |
#7 | Malkhosyan Sergei | 4 |
#8 | Welsh John T | 3 |
#9 | Youderian Phil | 2 |
#10 | Bourdon Mario | 2 |
Publication | Filing date | Title |
---|---|---|
WO9411531A1 | Identification of neoplasms by detection of genetic insertions and deletions | |
WO9207872A1 | Tenascin related peptides | |
US5190873A | Hybrid tryptophan aporepressor containing ligand binding sites | |
US5437975A | Consensus sequence primed polymerase chain reaction method for fingerprinting genomes | |
WO9103251A1 | Cr2 ligand compositions and methods for modulating immune cell functions | |
US5310729A | Interferon-related polypeptides as CR2 ligands and their use for modulating immune cell functions | |
US5331090A | CR2 ligand compositions and methods for modulating immune cell functions |